Skip to main content
Market Outlook Snapshot Market Dynamics Regional Forecast Country Insights Segment Analysis Competitive Landscape Industry News FAQ
On This Report

Single Use Ophthalmic Surgical Devices Market Size & Growth Forecast 2027–2036, By Segments (Product, End Use, Application), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Report ID: FBI 13289| Published Date: Jul-2026| Format: PDF, Excel
Market Outlook

Market Size and Growth Outlook

Single Use Ophthalmic Surgical Devices Market size was more than USD 9 billion in 2026 and is set to grow at a 7.6% CAGR between 2027 and 2036, reaching USD 18.72 billion by 2036. The industry revenue for 2027 is calculated at USD 9.58 billion.

Base Year Value (2026)
USD 9 billion
CAGR (2027-2036)
7.6%
Forecast Year Value (2036)
USD 18.72 billion
Historical Data Period
2022-2026
Largest Region
North America
Forecast Period
2027-2036

Get more details on this report

Request Free Sample Report
Snapshot

Single Use Ophthalmic Surgical Devices Market Intelligence Snapshot

Regional Market Dynamics

  • North America accounted for 35.93% of the market in 2026, driven by high ophthalmic surgery volumes, widespread disposable device adoption, and established hospital and ambulatory surgery infrastructure.
  • Asia Pacific is expected to expand at a 9.04% CAGR as access to eye care improves, surgical capacity increases, and healthcare providers adopt disposable devices for greater efficiency and hygiene.

Segment Momentum

  • Forceps dominate with a 20.68% share due to their essential role in tissue handling and precision manipulation across ophthalmic procedures, supported by sterility requirements and high procedural frequency in operating environments.
  • Ambulatory Surgical Centers are the fastest-growing end-use segment due to rising outpatient procedures, faster turnover needs, and operational efficiency advantages enabled by single-use sterile ophthalmic instruments.

Market Expansion Drivers

  • Increasing prevalence of ophthalmic disorders driving surgical device demand growth.
  • Rising preference for infection-free disposable surgical instruments in hospitals.
  • Expanding healthcare reimbursement and funding improving adoption of advanced surgical tools.

Leading Market Participants

  • Major companies in the single use ophthalmic surgical devices market include Alcon Vision LLC (United States), Bausch + Lomb Corporation (United States), Carl Zeiss Meditec AG (Germany), Mani, Inc. (Japan), Beaver-Visitec International, Inc. (United States), Appasamy Associates Private Limited (India), Accutome, Inc. (United States), Rumex International Co. (United States), Sterimedix Ltd. (United Kingdom), Corza Medical, Inc. (United States).

Forecast Snapshot

Global Market Forecast Snapshot

Market Outlook

  • 2026 Market Size: USD 9 billion
  • 2027 Estimated Market Size: USD 9.58 billion.
  • Projected Market Size: USD 18.72 billion by 2036
  • Growth Forecast: 7.6% CAGR (2027-2036)

Regional and Segment Outlook

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Forceps (Product) | Hospitals (End Use) | Cataract Surgery (Application)
  • Emerging Opportunity Segment: Knives (Product) | Ambulatory Surgical Centers (End Use) | Glaucoma Surgery (Application)
Market Dynamics

Market Growth Drivers and Industry Trends

Increasing prevalence of ophthalmic disorders driving surgical device demand growth

The rising incidence of cataracts, glaucoma, retinal disorders, and other ophthalmic conditions is strengthening demand across the single use ophthalmic surgical devices market as more patients require surgical intervention and specialized eye-care procedures. Population aging, increasing awareness of vision-related conditions, and improved access to diagnostic services are contributing to higher identification and treatment of ophthalmic disorders. Surgical procedures require precision instruments for tasks such as tissue manipulation, fluid management, incision, and implantation, creating recurring requirements for procedure-specific devices. The increasing volume and diversity of ophthalmic surgeries is consequently encouraging healthcare providers to maintain adequate supplies of sterile, procedure-ready instruments.

Rising preference for infection-free disposable surgical instruments in hospitals

The emphasis on infection prevention and sterile surgical environments is accelerating adoption within the single use ophthalmic surgical devices market as hospitals seek to reduce contamination risks associated with reusable instruments. Disposable devices arrive sterilized and are designed for use during a single procedure, eliminating the need for post-operative cleaning, disinfection, sterilization, and storage processes associated with reusable equipment. This approach can simplify surgical workflows while reducing opportunities for improper instrument reprocessing and cross-contamination, particularly in ophthalmic procedures where delicate ocular tissues require stringent infection-control practices. Hospitals are therefore increasingly evaluating disposable instruments as part of broader efforts to strengthen operating-room hygiene and streamline surgical preparation.

Expanding healthcare reimbursement and funding improving adoption of advanced surgical tools

Improving healthcare reimbursement coverage and greater funding for ophthalmic treatment are supporting the single use ophthalmic surgical devices market by making specialized procedures and associated surgical technologies more accessible to healthcare providers and patients. Favorable reimbursement environments can improve hospitals' ability to procure procedure-specific instruments while reducing financial barriers to ophthalmic interventions. Increased healthcare investment also enables facilities to modernize surgical departments and adopt technologies that improve procedural efficiency, precision, and infection control. As ophthalmic care becomes a greater component of healthcare expenditure and treatment access expands, providers have more opportunities to incorporate advanced disposable instruments into routine surgical practice.

Growth Driver Impact on CAGR Regulatory Influence Geographic Relevance Adoption Rate Impact Timeline
Increasing prevalence of ophthalmic disorders driving surgical device demand growth 2.40% High Asia Pacific, North America High Near Term
Rising preference for infection-free disposable surgical instruments in hospitals 2.10% High Europe, North America High Near Term
Expanding healthcare reimbursement and funding improving adoption of advanced surgical tools 1.90% High Global High Mid Term
Custom Research

Unlock insights tailored to your business with our bespoke market research solutions.

Click to get your customized report now.

Request Customization →
Regional Forecast

Regional Demand Dynamics

Single Use Ophthalmic Surgical Devices Market
Largest Region
North America
35.93% Market Share in 2026

North America (Largest Region)

North America held the largest share of the single use ophthalmic surgical devices market at 35.93% in 2026, supported by advanced ophthalmic care infrastructure, strong adoption of minimally invasive procedures, and established demand for sterile, procedure-specific medical devices. The region benefits from high awareness of infection prevention, sophisticated ambulatory and hospital-based surgical settings, and continued investment in modern ophthalmic technologies. Growing preference for disposable instruments that reduce sterilization requirements and support efficient surgical workflows further strengthens adoption across cataract, retinal, and other ophthalmic procedures.

Asia Pacific (Fastest-Growing Region)

Asia Pacific is the fastest-growing region, driven by expanding access to eye care, rising healthcare expenditure, and increasing demand for surgical treatment as healthcare infrastructure develops. Growing investments in hospitals and specialized ophthalmic centers are improving access to modern procedures, while greater awareness of infection control is supporting the transition toward single-use devices. Expanding medical technology adoption and efforts to improve surgical efficiency are also creating favorable conditions for disposable ophthalmic products across both established and emerging healthcare markets.

Parameter North America Asia Pacific Europe Latin America MEA
Innovation Hub i Scale Nascent Developing Advanced
Cost-Sensitive Region i Scale Low Medium High
Regulatory Environment i Scale Restrictive Neutral Supportive
Demand Drivers i Scale Weak Moderate Strong
Development Stage i Scale Emerging Developing Developed
Adoption Rate i Scale Low Medium High
New Entrants / Startups i Scale Sparse Moderate Dense
Macro Indicators i Scale Weak Stable Strong
Country Insights

Key Country Insights

Germany 🇩🇪

Precision Surgical Standards

Germany emphasizes high-quality single use ophthalmic surgical devices that support precision in cataract and retinal procedures. Hospitals in Germany prioritize dependable performance, product consistency, and compatibility with advanced surgical equipment.

France 🇫🇷

Infection Control Priority

France is reinforcing the adoption of single use ophthalmic surgical devices to strengthen infection prevention and standardized surgical practices. Healthcare providers in France increasingly evaluate products based on clinical reliability and procedural convenience.

Italy 🇮🇹

Ophthalmic Care Modernization

Italy is incorporating single use ophthalmic surgical devices into ophthalmic care as healthcare facilities modernize surgical workflows. Providers in Italy focus on practical device handling, procedural consistency, and compliance with evolving clinical standards.

Japan 🇯🇵

Advanced Surgical Reliability

Japan continues integrating single use ophthalmic surgical devices into high-volume ophthalmic care to support procedural consistency and patient safety. Medical facilities in Japan value precision manufacturing and dependable clinical performance across specialized procedures.

South Korea 🇰🇷

Modern Clinical Adoption

South Korea is expanding the use of single use ophthalmic surgical devices as ophthalmic clinics modernize surgical practices. Providers in South Korea seek products that improve operational efficiency while supporting high standards of patient care.

United States 🇺🇸

Procedure Efficiency Focus

The U.S. healthcare sector continues adopting single use ophthalmic surgical devices to improve workflow efficiency and infection control during ophthalmic procedures. Healthcare providers in the U.S. increasingly value consistent device performance and regulatory compliance.

Segment Analysis

Segment Leadership and Growth Trends

Single Use Ophthalmic Surgical Devices Market Share (%), by Product, 2026

Forceps
OVD
Knives
Cannulas
Speculum
Others

Go beyond the chart, access full insights & data tables

Request Free Sample Report

Product Segment Analysis: Forceps (Largest Segment) vs Knives (Fastest-Growing Segment)

Forceps represented the largest product segment of the single use ophthalmic surgical devices market, with a 20.68% share in 2026. Their broad use in tissue handling, manipulation, and other ophthalmic procedures supports consistent demand across surgical settings. The growing emphasis on sterile, procedure-specific instruments and the advantages of single-use devices in reducing contamination risks continue to strengthen the role of forceps.

Knives are gaining momentum as ophthalmic procedures increasingly require precise, controlled tissue incision. Advances in minimally invasive surgical techniques and greater emphasis on procedural accuracy are supporting demand for specialized cutting instruments. The shift toward efficient, sterile, and application-specific surgical workflows is further creating opportunities for single-use ophthalmic knives.

End Use Segment Analysis: Hospitals (Largest Segment) vs Ambulatory Surgical Centers (Fastest-Growing Segment)

In the single use ophthalmic surgical devices market, hospitals accounted for the largest share at 32.54% in 2026, reflecting their extensive ophthalmic surgical infrastructure and ability to accommodate a broad range of complex procedures. Hospitals also benefit from specialized surgical teams, established sterilization protocols, and comprehensive patient-care capabilities. Continued investment in ophthalmic services and procedural infrastructure supports sustained demand for disposable surgical devices in hospital settings.

Ambulatory surgical centers are expanding as ophthalmic procedures increasingly shift toward efficient outpatient care models. These facilities can support streamlined procedures and shorter patient stays while maintaining controlled surgical environments, making them well suited to many ophthalmic interventions. Increasing emphasis on cost-efficient care, minimally invasive techniques, and procedural convenience is encouraging greater use of single-use ophthalmic devices in ambulatory settings.

Segment Sub-Segment Largest Segment Fastest Growing
Product Forceps, Speculum, Nucleus Rotators & Choppers, Curettes, Cannulas, Knives, OVD, Others Forceps Knives
End Use Hospitals, Ophthalmic Clinics, Ambulatory Surgical Centers, Others Hospitals Ambulatory Surgical Centers
Application Cataract Surgery, Glaucoma Surgery, Refractive Surgery, Others Cataract Surgery Glaucoma Surgery
Competitive Landscape

Competitive Landscape and Market Positioning

Top players in the single use ophthalmic surgical devices market:

1. Alcon Vision LLC (United States)

2. Bausch + Lomb Corporation (United States)

3. Carl Zeiss Meditec AG (Germany)

4. Mani Inc. (Japan)

5. Beaver-Visitec International Inc. (United States)

6. Appasamy Associates Private Limited (India)

7. Accutome Inc. (United States)

8. Rumex International Co. (United States)

9. Sterimedix Ltd. (United Kingdom)

10. Corza Medical Inc. (United States)

The single use ophthalmic surgical devices market is advancing as demand grows for safer and more efficient surgical procedures. Innovation in disposable device design is improving sterility and procedural precision. Continuous development efforts are enhancing surgical workflow efficiency and patient outcomes. The single use ophthalmic surgical devices market is increasingly shaped by the shift toward minimally invasive and infection-controlled solutions.

Company Market Share Company Revenue Revenue CAGR (%) Product Portfolio Geographic Presence Innovation / R&D Focus Strategic Developments
Alcon Vision LLC (United States)
Bausch + Lomb Corporation (United States)
Carl Zeiss Meditec AG (Germany)
Mani Inc. (Japan)
Beaver-Visitec International Inc. (United States)
Appasamy Associates Private Limited (India)
Accutome Inc. (United States)
Rumex International Co. (United States)
Sterimedix Ltd. (United Kingdom)
Corza Medical Inc. (United States).
🔒 This section is available as a standalone purchase. Buy only the data you need. Inquire Before Buying
Industry News

Industry Development/News

Company Name Date Key Development
BVI Sep-23 BVI acquired Medical Mix, an ophthalmic surgical device provider operating in Portugal and Spain, strengthening its commercial and distribution footprint in key European markets. The acquisition enhances BVI’s regional presence and supports expansion of its single-use ophthalmic surgical device portfolio across established healthcare networks.
BVI Jun-23 BVI introduced FINEVISION HP in Japan, a hydrophobic trifocal intraocular lens designed to deliver improved visual outcomes for cataract patients. The product represents an advanced ophthalmic innovation expanding BVI’s premium intraocular lens portfolio within the Japanese surgical ophthalmology market.
Report Customization

Customize Your Report

Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.

1 Custom Segments 2 Custom TOC 3 Related Reports

Single Use Ophthalmic Surgical Devices Market — Custom Segments

Segment Sub-Segment
Procurement Model Direct Procurement, Group Purchasing Organizations, Distributor Procurement
Regulatory Classification Class I, Class II, Class III
Procedure Stage Preoperative Preparation, Surgical Intervention, Postoperative Care

Single Use Ophthalmic Surgical Devices Market — Custom TOC

Custom Chapter Custom Details
Surgical Workflow Efficiency and Infection Control Strategy
  • Procedure Workflow Optimization Opportunities
  • Single-Use Device Adoption and Operational Efficiency
  • Infection Prevention Priorities Across Ophthalmic Procedures
  • Sterility Management and Workflow Integration
  • Adoption Barriers and Implementation Priorities
Hospital Procurement Strategy and Decision-Making
  • Procurement Priorities for Single-Use Ophthalmic Devices
  • Clinical, Operational, and Economic Evaluation Criteria
  • Supplier Selection and Contracting Considerations
  • Purchasing Models Across Hospital Settings
  • Procurement Transformation Opportunities
Ambulatory Surgery Center Opportunity Mapping
  • Ophthalmic Procedure Migration to Ambulatory Settings
  • Device Utilization Requirements in Ambulatory Surgery Centers
  • Operational and Procurement Considerations
  • Adoption Opportunities Across High-Volume Procedures

Need a different cut of the data?

Request Custom Research
Frequently Asked Questions

How big is the single use ophthalmic surgical devices market?

The market valuation of the single use ophthalmic surgical devices is USD 9.58 billion in 2027.

How is the single use ophthalmic surgical devices industry projected to perform over the next decade?

Single Use Ophthalmic Surgical Devices Market size was more than USD 9 billion in 2026 and is set to grow at a 7.6% CAGR between 2027 and 2036, reaching USD 18.72 billion by 2036.

How is rising ophthalmic disease prevalence influencing adoption of single use surgical devices?

Increasing cases of cataracts, glaucoma, and retinal disorders are driving higher surgical volumes, supporting demand for disposable instruments. Providers prefer single use tools to ensure consistency, reduce turnaround time, and manage high procedural throughput.

What role does infection control and hospital efficiency play in driving disposable ophthalmic device adoption?

Strong focus on infection prevention and standardization is increasing preference for disposable tools. They eliminate sterilization variability, reduce cross-contamination risks, and streamline workflows, supporting safer and more efficient ophthalmic surgical operations.

Why do Forceps lead the single use ophthalmic surgical devices market?

Forceps dominate with a 20.68% share due to their essential role in tissue handling and precision manipulation across ophthalmic procedures, supported by sterility requirements and high procedural frequency in operating environments.

How are Ambulatory Surgical Centers driving market growth?

Ambulatory Surgical Centers are the fastest-growing end-use segment due to rising outpatient procedures, faster turnover needs, and operational efficiency advantages enabled by single-use sterile ophthalmic instruments.

Why is North America the largest market for single use ophthalmic surgical devices?

North America accounted for 35.93% of the market in 2026, driven by high ophthalmic surgery volumes, widespread disposable device adoption, and established hospital and ambulatory surgery infrastructure.

Why is Asia Pacific the fastest-growing region in the single use ophthalmic surgical devices market?

Asia Pacific is expected to expand at a 9.04% CAGR as access to eye care improves, surgical capacity increases, and healthcare providers adopt disposable devices for greater efficiency and hygiene.

Who are the major participants shaping the single use ophthalmic surgical devices landscape?

Major companies in the single use ophthalmic surgical devices market include Alcon Vision LLC (United States), Bausch + Lomb Corporation (United States), Carl Zeiss Meditec AG (Germany), Mani, Inc. (Japan), Beaver-Visitec International, Inc. (United States), Appasamy Associates Private Limited (India), Accutome, Inc. (United States), Rumex International Co. (United States), Sterimedix Ltd. (United Kingdom), Corza Medical, Inc. (United States).
Testimonials

Our Clients

"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."

Project Manager
Siemens Healthcare

"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."

Research and Development (R&D) Manager
GC Biopharma

"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."

Quality Assurance Manager
Medtronic
THE RESEARCH BEHIND THIS REPORT

Our Research Team & Methodology

Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.

THIS REPORT'S RESEARCH VERTICAL

Research Team Overview

♢
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.

Prepared by the Healthcare & Medical Devices Research Team

10+
Industry Verticals
100+
Countries Analyzed
5–7
Days Standard
Delivery
12k+
Research Reports
Published
On-
Demand
Customized Research
Available
6
Months Analyst
Support
PDF + XLS
Report Deliverables

Trust & Compliance

☷D&B D-U-N-S
♢GDPR & CCPA Compliant
♙ISO 9001 Certified (ISO 9001:2015)
♙SSL Encryption
▭Secure Payments
✓Confidential Handling

Research Domains

10 coverage areas
Medical Devices & Equipment Diagnostic Imaging Clinical Diagnostics Digital Health & Telemedicine Patient Monitoring Systems Surgical & Minimally Invasive Technologies Healthcare IT & Data Systems Biotechnology & Life Sciences Pharmaceutical Technologies Healthcare Delivery & Services

Research Intelligence

Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts

Research Workflow & Quality Assurance

📥
01

Data Collection

Verified information gathered through primary and secondary research.

🔍
02

Data Triangulation

Cross-validation using multiple independent data sources.

📈
03

Forecast Modelling

Market estimates developed using historical trends and analytical models.

👨‍💼
04

Analyst Validation

Findings reviewed by domain experts for accuracy and consistency.

📝
05

Editorial & Quality Review

Final editorial, quality, and compliance checks before publication.

✅
06

Final Publication

Released after successful completion of the internal review process.

Report Coverage

📊 Market Assessment

  • Market Size & Forecast
  • Market Segmentation
  • Regional Analysis
  • Growth Drivers & Challenges
  • Market Dynamics

🏢 Competitive Intelligence

  • Competitive Landscape
  • Company Profiles
  • Competitive Benchmarking
  • Mergers & Acquisitions
  • Market Share Analysis or Key Company Strategies

🔍 Strategic Analysis

  • Value Chain Analysis
  • Porter's Five Forces
  • PESTLE Analysis
  • Pricing Trends
  • Supply-Demand Analysis

🚀 Future Outlook

  • Technology Landscape
  • Regulatory Landscape
  • Investment & Funding Landscape
  • Emerging Opportunities
  • Future Market Outlook

Have a question about this report or need a custom scope?

Request Customization
License

Select License Type

Single User
US$ 4,250
Buy Now
Corporate User
US$ 6,150
Buy Now

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →